Skip to main content

Table 1 Baseline characteristics by trial arm of participants who subsequently became pregnant or remained non-pregnant during follow-up

From: Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection – a double blind, randomised controlled trial in Burkina Faso

Variable

Pregnant cohort

Non-pregnant cohort

Na

Iron

Control

Na

Iron

Control

 

N = 258

N = 220

 

N = 766

N = 783

Sociodemographic

Age, years, mean (SD)

478

17.1 (1.7)

17.1 (1.7)

1549

16.7 (1.7)

16.7 (1.8)

 Ethnic group, n (%)

  Mossi

478

250 (96.9)

214 (97.3)

1548

730 (95.3)

757 (96.8)

  Other

478

8 (3.1)

6 (2.7)

1548

36 (4.7)

25 (3.2)

 Marital status

      

  Married

478

22 (8.5)

15 (6.8)

1544

17 (2.2)

18 (2.3)

  Never married

478

236 (91.5)

204 (92.7)

1544

748 (97.8)

760 (97.6)

  Previously married

478

0 (0)

1 (0.5)

1544

0 (0)

1 (0.1)

 Occupation,b n (%)

  Student

478

60 (23.3)

51 (23.2)

1549

255 (33.3)

274 (35.0)

  Trading

478

10 (3.9)

10 (4.5)

1549

24 (3.1)

21 (2.7)

  Domestic labour

478

154 (59.7)

120 (54.5)

1549

401 (52.3)

407 (52.0)

  Farming

478

130 (50.4)

101 (45.9)

1549

269 (35.1)

290 (37.0)

  Other

478

3 (1.2)

3 (1.4)

1549

3 (0.4)

2 (0.3)

 Education, n (%)

  No schooling

477

176 (68.5)

142 (64.5)

1544

447 (58.6)

450 (57.6)

  Primary

478

54 (20.9)

38 (17.3)

1549

168 (21.9)

169 (21.6)

  Lower secondary

477

24 (9.3)

38 (17.3)

1544

144 (18.9)

153 (19.6)

  Higher secondary

477

3 (1.2)

2 (0.9)

1544

4 (0.5)

9 (1.2)

 Literate, n (%)

473

68 (26.7)

62 (28.4)

1530

278 (36.8)

297 (38.4)

Reproductive history and infections, n (%)

 Menarcheal

478

241 (93.4)

203 (92.3)

1549

639 (83.4)

645 (82.4)

 Menarche age, mean (SD)

443

14.9 (1.0)

14.8 (1.1)

1279

15 (1.0)

15.1 (1.1)

 Ever had sex

478

98 (38)

82 (37.3)

1548

159 (20.8)

164 (21.0)

 Uses contraception

478

54 (20.9)

51 (23.2)

1549

106 (13.8)

86 (11.0)

 Uses condoms

478

53 (20.5)

50 (22.7)

1549

103 (13.4)

81 (10.3)

 Nugent 7–10

391

33 (15.7)

23 (12.7)

1247

80 (13.0)

68 (10.8)

 Nugent 4–6

391

17 (8.1)

11 (6.1)

1247

49 (8.0)

66 (10.5)

 Nugent 0–3

391

160 (76.2)

147 (81.2)

1247

487 (79.1)

497 (78.8)

 Vaginal discharge

478

3 (1.2)

4 (1.8)

1549

13 (1.7)

12 (1.5)

 Vaginal pH ≥ 4.5

394

119 (55.9)

84 (46.4)

1280

317 (50.3)

328 (50.5)

Nutrition and iron biomarkers, n (%)

 Drinks alcohol

476

140 (54.5)

119 (54.3)

1549

372 (48.6)

380 (48.5)

 BMI, kg/m2, mean (SD)

478

20.2 (1.8)

20.3 (2.1)

1549

19.7 (2.2)

19.6 (2.2)

 MUAC, cm, mean (SD)

478

24.1 (1.8)

24.3 (2.2)

1549

23.6 (2.1)

23.6 (2.2)

 Iron deficient (adjFE)

467

25 (10.0)

26 (12.0)

1528

84 (11.1)

100 (13.0)

 Iron deficient (ratio sTfR/log ferritin)

470

52 (20.6)

55 (25.3)

1524

162 (21.4)

168 (21.9)

Adherence to treatment

 DOT,c mean (SD)

478

70.3 (27.0)

71.4 (26.0)

1549

70.0 (27.8)

70.8 (26.3)

  1. aTotal responders
  2. bMore than one response allowed
  3. cNumber of directly observed treatments as a percentage of the number of weeks from enrolment to assessment
  4. adjFE adjusted ferritin, BMI body mass index, DOT directly observed treatment, MUAC mid-upper arm circumference, SD standard deviation, sTfR serum transferrin receptor